Periodic Reporting for period 1 - GlycoMabs (Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies)

Monoclonal antibodies (mAbs) are a prominent and rapidly expanding class of drugs used to treat various diseases, e.g., cancer, autoimmunity, neurodegenerative and infectious diseases, among others. Most of the therapeutically available mAbs are based on immunoglobulin G...